InsiderClue
Insiders · Profile

Slagel Dean

Director at Tvardi Therapeutics. Filing since 15 May 2015. CIK 0001597359

Company
Date
Role
Action
Shares
Amount
Of holding
TVRD Tvardi Therapeutics, Inc.
29 Jun 2017
Director
Sold, plan not stated
250,000
$6.47M
19.0%
TVRD Tvardi Therapeutics, Inc.
5 Jan 2016
Director
Sold, plan not stated
31,224
$531.12K
2.3%
TVRD Tvardi Therapeutics, Inc.
31 Dec 2015
Director
Sold, plan not stated
12,776
$217.19K
0.9%
TVRD Tvardi Therapeutics, Inc.
19 May 2015
Director
Sold, plan not stated
32,266
$322.66K
2.3%
TVRD Tvardi Therapeutics, Inc.
18 May 2015
Director
Sold, plan not stated
82,945
$832.77K
5.6%
TVRD Tvardi Therapeutics, Inc.
15 May 2015
Director
Sold, plan not stated
73,600
$736.00K
4.8%
6 decisions on file.